Commonwealth Equity Services’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,631
Closed -$289K 4342
2025
Q3
$289K Sell
19,631
-2,875
-13% -$29.3K ﹤0.01% 3682
2025
Q2
$221K Sell
22,506
-1,386
-6% -$11.5K ﹤0.01% 3839
2025
Q1
$174K Buy
23,892
+204
+0.9% +$1.78K ﹤0.01% 3879
2024
Q4
$185K Buy
23,688
+75
+0.3% +$618 ﹤0.01% 3794
2024
Q3
$175K Buy
23,613
+320
+1% +$2.69K ﹤0.01% 3753
2024
Q2
$187K Buy
23,293
+12,600
+118% +$113K ﹤0.01% 3657
2024
Q1
$124K Buy
10,693
+190
+2% +$2.1K ﹤0.01% 3760
2023
Q4
$117K Buy
+10,503
New +$96.5K ﹤0.01% 3640

Other funds holding ETNB

Commonwealth Equity Services's ETNB Position: Q4 2025 in Review

Commonwealth Equity Services sold out of 89bio (ETNB) in Q4 2025, closing a stake of 19,631 shares — an estimated $289K sold.

Commonwealth Equity Services first reported a position in ETNB in Q4 2023 and held it in 8 quarters. The position peaked at $289K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Commonwealth Equity Services reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 19,631 89bio shares in Q4 2025, an estimated $289K.
  • Commonwealth Equity Services first reported a position in 89bio in Q4 2023 and held it in 8 quarters.
  • Commonwealth Equity Services's 89bio position peaked at $289K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.